Tissue Solutions has been acquired by BioIVTTissue Solutions has been acquired by BioIVT, a leading provider of research models, biospecimens and related services for drug discovery and development
- July 19, 2021
- Posted by: Lauren Vagnone
- Category: News
Tissue Solutions has been acquired by BioIVT, a leading provider of research models, biospecimens and related services for drug discovery and development
This is exciting news, as we combine Tissue Solutions’ expertise in high-quality biologicals, diagnostic reagent products and contract manufacturing services with BioIVT’s expansive offering of sera and plasma collected from clinical sites, covering a wide breadth of physician-confirmed indications.
Moving forward, you can expect:
- Continued service for all your cell culture and in vitro diagnostic research and development needs.
- Your current contacts, active contracts and ordering process to remain the same; there will be no changes when placing orders.
- A renewed commitment to providing the highest quality products and superior customer support.
By joining BioIVT, we can now also serve as your go-to partner for human/animal biospecimens, hepatic products and services and other in vitro research needs. We invite you to explore our cell and gene therapy and diagnostic solutions. Our complete product portfolio can be found here.
For more information about this acquisition, please read the press release.